# FDA Inspection 1102583 - Sarah D. Atkinson, M.D. - September 10, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/sarah-d-atkinson-md/71428de7-11e4-4d09-8b0b-5d6a4c046ea0
Source feed: FDA_Inspections

> FDA Inspection 1102583 for Sarah D. Atkinson, M.D. on September 10, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102583
- Company Name: Sarah D. Atkinson, M.D.
- Inspection Date: 2019-09-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1150163 - 2021-07-20](https://www.globalkeysolutions.net/records/fda_inspections/sarah-d-atkinson-md/aed913df-200b-4af5-ad87-8349463b3be6)
- [FDA Inspection 1050534 - 2018-04-27](https://www.globalkeysolutions.net/records/fda_inspections/sarah-d-atkinson-md/657cc559-d4e4-44cc-a426-9f92178a9b20)
- [FDA Inspection 790658 - 2012-07-13](https://www.globalkeysolutions.net/records/fda_inspections/sarah-d-atkinson-md/594d0025-8613-4143-bd22-b34b3e98466d)

Company: https://www.globalkeysolutions.net/companies/sarah-d-atkinson-md/b30a86b0-85c7-4013-80e1-6f71c515cc3a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c